{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:15:52Z","timestamp":1793229352608,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06042-0","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:01:09Z","timestamp":1783576869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10"],"prefix":"10.1007","volume":"63","author":[{"given":"Pingting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuanlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"6042_CR1","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023 19(4): 1598-695","DOI":"10.1002\/alz.13016"},{"issue":"2","key":"6042_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339","journal-title":"Cell"},{"issue":"5","key":"6042_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2021.0178","volume":"78","author":"IM Nasrallah","year":"2021","unstructured":"Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB et al (2021) Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND randomized trial. JAMA Neurol 78(5):568\u2013577","journal-title":"JAMA Neurol"},{"issue":"9","key":"6042_CR4","first-page":"1000","volume":"16","author":"M Putteeraj","year":"2017","unstructured":"Putteeraj M, Fairuz YM, Teoh SL (2017) MicroRNA dysregulation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 16(9):1000\u20131009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"6042_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111352","volume":"191","author":"AD Henriques","year":"2020","unstructured":"Henriques AD, Machado-Silva W, Leite REP, Suemoto CK, Leite KRM, Srougi M et al (2020) Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer\u2019s disease. Mech Ageing Dev 191:111352","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"6042_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11064-020-03096-x","volume":"45","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang H, Sun L, Zhu K, Lang W (2020) miR-29c-3p increases cell viability and suppresses apoptosis by regulating the TNFAIP1\/NF-\u03baB signaling pathway via TNFAIP1 in A\u03b2-treated neuroblastoma cells. Neurochem Res 45(10):2375\u201384","journal-title":"Neurochem Res"},{"issue":"10","key":"6042_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139233","volume":"10","author":"G Lugli","year":"2015","unstructured":"Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG et al (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One 10(10):e0139233","journal-title":"PLoS One"},{"issue":"6","key":"6042_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s11011-022-01017-1","volume":"37","author":"XY Luo","year":"2022","unstructured":"Luo XY, Ying JH, Wang QS (2022) MiR-25-3p ameliorates SAE by targeting the TLR4\/NLRP3 axis. Metab Brain Dis 37(6):1803\u20131813","journal-title":"Metab Brain Dis"},{"issue":"1","key":"6042_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5603\/FHC.a2021.0004","volume":"59","author":"X He","year":"2021","unstructured":"He X, Deng L (2021) Potential of miR-25-3p in protection of chondrocytes: emphasis on osteoarthritis. Folia Histochem Cytobiol 59(1):30\u201339","journal-title":"Folia Histochem Cytobiol"},{"issue":"9\u201310","key":"6042_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/03630242.2022.2108193","volume":"62","author":"D Zhou","year":"2022","unstructured":"Zhou D, Qu B, Zhang X (2022) Diagnostic value of serum miR-25-3p in hypertensive disorders in pregnancy. Women Health 62(9\u201310):818\u2013826","journal-title":"Women Health"},{"issue":"9","key":"6042_CR11","doi-asserted-by":"publisher","first-page":"15891","DOI":"10.1002\/jcb.28861","volume":"120","author":"Q Duan","year":"2019","unstructured":"Duan Q, Si E (2019) MicroRNA-25 aggravates A\u03b21-42-induced hippocampal neuron injury in Alzheimer\u2019s disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. J Cell Biochem 120(9):15891\u201315905","journal-title":"J Cell Biochem"},{"key":"6042_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914749","author":"C Visconte","year":"2023","unstructured":"Visconte C, Fenoglio C, Serpente M, Muti P, Sacconi A, Rigoni M et al (2023) Altered extracellular vesicle miRNA profile in prodromal Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914749","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6042_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","volume":"58","author":"XZ Yuan","year":"2017","unstructured":"Yuan XZ, Sun S, Tan CC, Yu JT, Tan L (2017) The role of ADAM10 in Alzheimer\u2019s disease. J Alzheimers Dis 58(2):303\u2013322","journal-title":"J Alzheimers Dis"},{"key":"6042_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1056507","volume":"14","author":"RJ Elsworthy","year":"2022","unstructured":"Elsworthy RJ, Hill EJ, Dunleavy C, Aldred S (2022) The role of ADAM10 in astrocytes: implications for Alzheimer\u2019s disease. Front Aging Neurosci 14:1056507","journal-title":"Front Aging Neurosci"},{"key":"6042_CR15","doi-asserted-by":"crossref","unstructured":"Oliveira Monteiro EPdAMP, Valle Pedroso R, Mantellatto Grigoli M, Vicente Silva T, Manzine PR Cominetti MR (2024) ADAM10 as a biomarker for Alzheimer's disease: A systematic review. Rev Neurol (Paris) 180(1\u20132): 1\u201311","DOI":"10.1016\/j.neurol.2023.04.002"},{"issue":"1","key":"6042_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1255-9","volume":"15","author":"A Sogorb-Esteve","year":"2018","unstructured":"Sogorb-Esteve A, Garc\u00eda-Ayll\u00f3n MS, Gobom J, Alom J, Zetterberg H, Blennow K et al (2018) Levels of ADAM10 are reduced in Alzheimer\u2019s disease CSF. J Neuroinflammation 15(1):213","journal-title":"J Neuroinflammation"},{"issue":"8","key":"6042_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J et al (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734\u2013746","journal-title":"Lancet Neurol"},{"key":"6042_CR18","doi-asserted-by":"crossref","unstructured":"Subramanian S, Krishna G, Sivakumar PT, Dahale AB, Kumar JS, Sinha P et al (2021) Plasma neurofilament L to amyloid \u03b242 ratio in differentiating Alzheimer's type from non-Alzheimer's dementia: A cross-sectional pilot study from India. Asian J Psychiatr. 66102914","DOI":"10.1016\/j.ajp.2021.102914"},{"key":"6042_CR19","doi-asserted-by":"crossref","unstructured":"Pang QQ, Kim JH, Choi JM, Song JL, Lee S, Cho EJ (2022) Cirsium japonicum var. Maackii improves cognitive impairment under amyloid beta(25\u201335)-induced Alzheimer's disease model. BioMed Res Int 2022:4513998","DOI":"10.1155\/2022\/4513998"},{"issue":"9","key":"6042_CR20","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s10529-020-02915-z","volume":"42","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chang Q (2020) MicroRNA miR-212 regulates PDCD4 to attenuate A\u03b2(25\u201335)-induced neurotoxicity via PI3K\/AKT signaling pathway in Alzheimer\u2019s disease. Biotechnol Lett 42(9):1789\u20131797","journal-title":"Biotechnol Lett"},{"issue":"3","key":"6042_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000519780","volume":"29","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu Y, Teng P, Yang Q (2022) Differential expression of miR-381-3p in Alzheimer\u2019s disease patients and its role in beta-amyloid-induced neurotoxicity and inflammation. Neuroimmunomodulation 29(3):211\u2013219","journal-title":"Neuroimmunomodulation"},{"key":"6042_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/23337214221123733","volume":"8","author":"BM Howell","year":"2022","unstructured":"Howell BM, Piech A, Wolfe C (2022) Pilot of a communication program for dementia caregivers using improvisational techniques. Gerontol Geriatr Med 8:23337214221123733","journal-title":"Gerontol Geriatr Med"},{"key":"6042_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2013.00059","author":"MA Meraz-R\u00edos","year":"2013","unstructured":"Meraz-R\u00edos MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hern\u00e1ndez J, Campos-Pe\u00f1a V (2013) Inflammatory process in Alzheimer\u2019s disease. Front Integr Neurosci. https:\/\/doi.org\/10.3389\/fnint.2013.00059","journal-title":"Front Integr Neurosci"},{"issue":"3","key":"6042_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","volume":"16","author":"R Briggs","year":"2016","unstructured":"Briggs R, Kennelly SP, O\u2019Neill D (2016) Drug treatments in Alzheimer\u2019s disease. Clin Med (Lond) 16(3):247\u201353","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"6042_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.13207","volume":"25","author":"T Deng","year":"2025","unstructured":"Deng T, Yu W, L\u00fc Y (2025) Different physical exercise in the treatment of Alzheimer\u2019s disease. Psychogeriatr 25(1):e13207","journal-title":"Psychogeriatr"},{"key":"6042_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111080","author":"R Wang","year":"2020","unstructured":"Wang R, Zhang J (2020) Clinical significance of miR-433 in the diagnosis of Alzheimer\u2019s disease and its effect on A\u03b2-induced neurotoxicity by regulating JAK2. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2020.111080","journal-title":"Exp Gerontol"},{"key":"6042_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111187","author":"Q Liu","year":"2021","unstructured":"Liu Q, Lei C (2021) Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer\u2019s disease. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2020.111187","journal-title":"Exp Gerontol"},{"issue":"1\u20132","key":"6042_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N et al (2014) Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 336(1\u20132):52\u201356","journal-title":"J Neurol Sci"},{"issue":"2","key":"6042_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u201372","journal-title":"J Cell Biol"},{"issue":"2","key":"6042_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129(2):183\u2013206","journal-title":"Acta Neuropathol"},{"issue":"33","key":"6042_CR31","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci 28(33):8354\u20138360","journal-title":"J Neurosci"},{"issue":"1","key":"6042_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonz\u00e1lez-Billault C, Maccioni RB (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res 295(1):245\u2013257","journal-title":"Exp Cell Res"},{"issue":"1","key":"6042_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"6042_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00441-011-1230-6","volume":"347","author":"F Caraci","year":"2012","unstructured":"Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V et al (2012) Dysfunction of TGF-\u03b21 signaling in Alzheimer\u2019s disease: perspectives for neuroprotection. Cell Tissue Res 347(1):291\u2013301","journal-title":"Cell Tissue Res"},{"key":"6042_CR35","doi-asserted-by":"crossref","unstructured":"Sun X, Deng Y, Ge P, Peng Q, Soufiany I, Zhu L et al (2023) Diminazene ameliorates neuroinflammation by suppression of astrocytic miRNA-224\u20135p\/NLRP3 axis in Alzheimer's disease model. J Inflamm Res 16:1639\u20131652","DOI":"10.2147\/JIR.S401385"},{"issue":"6","key":"6042_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1567205016666190503145207","volume":"16","author":"D Liu","year":"2019","unstructured":"Liu D, Zhao D, Zhao Y, Wang Y, Zhao Y, Wen C (2019) Inhibition of microRNA-155 alleviates cognitive impairment in Alzheimer\u2019s disease and involvement of neuroinflammation. Curr Alzheimer Res 16(6):473\u2013482","journal-title":"Curr Alzheimer Res"},{"key":"6042_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147511","volume":"1766","author":"P Shao","year":"2021","unstructured":"Shao P (2021) MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer\u2019s disease mice via regulation of HMGB1\/NF-\u03baB signaling. Brain Res 1766:147511","journal-title":"Brain Res"},{"issue":"1","key":"6042_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1260-z","volume":"15","author":"X Zhu","year":"2018","unstructured":"Zhu X, Li X, Zhu M, Xu K, Yang L, Han B et al (2018) Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation. J Neuroinflammation 15(1):221","journal-title":"J Neuroinflammation"},{"key":"6042_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxlet.2019.10.005","volume":"318","author":"JH Park","year":"2020","unstructured":"Park JH, Choi JY, Jo C, Koh YH (2020) Involvement of ADAM10 in acrolein-induced astrocytic inflammation. Toxicol Lett 318:44\u201349","journal-title":"Toxicol Lett"},{"key":"6042_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neurobiolaging.2017.11.007","volume":"63","author":"R Akhter","year":"2018","unstructured":"Akhter R, Shao Y, Shaw M, Formica S, Khrestian M, Leverenz JB et al (2018) Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer\u2019s disease. Neurobiol Aging 63:110\u2013119","journal-title":"Neurobiol Aging"},{"issue":"5","key":"6042_CR41","first-page":"405","volume":"35","author":"D Hu","year":"2019","unstructured":"Hu D, Luo H (2019) miR-25-3p down-regulates the expression of ADAM10 to inhibit the differentiation of P19 cells into cardiomyocytes by blocking the Notch signaling pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 35(5):405\u2013411","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"9","key":"6042_CR42","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. J Clin Invest 127(9):3240\u20133249","journal-title":"J Clin Invest"},{"issue":"1","key":"6042_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06042-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:01:11Z","timestamp":1783576871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06042-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6042"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06042-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Xijing Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"751"}}